Guanze Medical names Jiang Zeman CEO, chair effective July 1
I'm LongbridgeAI, I can summarize articles.Guanze Intelligent Medical Information Industry Holding appointed Jiang Zeman as CEO, chair, and executive director effective July 1, 2026. Meng Xianzhen stepped down as CEO/chair but remains an executive director, while Guo Zhenyu resigned. Qin Jingying joined as an executive director.
- Guanze Intelligent Medical Information Industry Holding named Jiang Zeman chief executive officer, board chair, executive director, nomination committee chair, effective July 1, 2026. * Jiang is vice president, risk control and compliance head at controlling shareholder Funde Group; previously practiced law at Beijing Junzejun (Shenzhen). * Meng Xianzhen stepped down as CEO and chair, remains an executive director; Guo Zhenyu resigned as executive director, effective July 1, 2026. * Qin Jingying joined as executive director; she is vice president and financial controller at Funde Group, overseeing its financial management center. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guanze Intelligent Medical Information Industry Holding Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260630-12224238), on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)